HBIO icon

Harvard Bioscience

98 hedge funds and large institutions have $187M invested in Harvard Bioscience in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 40 reducing their positions, and 12 closing their positions.

Holders
98
Holders Change
-5
Holders Change %
-4.85%
% of All Funds
1.55%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
27
Reduced
40
Closed
12
Calls
$32K
Puts
$4K
Net Calls
+$28K
Net Calls Change
+$41K
Name Holding Trade Value Shares
Change
Shares
Change %
RJA
101
Raymond James & Associates
Florida
-$240K -34,018 Closed
Susquehanna International Group
102
Susquehanna International Group
Pennsylvania
-$163K -23,061 Closed
B
103
Bailard
California
-$104K -14,700 Closed
Squarepoint
104
Squarepoint
New York
-$94K -13,397 Closed
WG
105
Winton Group
United Kingdom
-$86K -12,216 Closed
DWA
106
Dorsey Wright & Associates
California
-$55K -7,740 Closed
Simplex Trading
107
Simplex Trading
Illinois
-$11K -1,660 Closed
Federated Hermes
108
Federated Hermes
Pennsylvania
-$6K -845 Closed
TCWM
109
Total Clarity Wealth Management
Illinois
-$6K -811 Closed
Group One Trading
110
Group One Trading
Illinois
-$2K -300 Closed